Relapse prevention for addictive behaviors.
paper
Cited
Public
- Authors
- Hendershot, Christian S; Witkiewitz, Katie; George, William H; Marlatt, G Alan
- Year
- 2011
- Journal
- Substance abuse treatment, prevention, and policy
- PMID
- 21771314
- DOI
- 10.1186/1747-597X-6-17
- PMCID
- PMC3163190
The Relapse Prevention (RP) model has been a mainstay of addictions theory and treatment since its introduction three decades ago. This paper provides an overview and update of RP for addictive behaviors with a focus on developments over the last decade (2000-2010). Major treatment outcome studies and meta-analyses are summarized, as are selected empirical findings relevant to the tenets of the RP model. Notable advances in RP in the last decade include the introduction of a reformulated cognitive-behavioral model of relapse, the application of advanced statistical methods to model relapse in large randomized trials, and the development of mindfulness-based relapse prevention. We also review the emergent literature on genetic correlates of relapse following pharmacological and behavioral treatments. The continued influence of RP is evidenced by its integration in most cognitive-behavioral substance use interventions. However, the tendency to subsume RP within other treatment modalities has posed a barrier to systematic evaluation of the RP model. Overall, RP remains an influential cognitive-behavioral framework that can inform both theoretical and clinical approaches to understanding and facilitating behavior change.
Original cognitive-behavioral model of relapse (Marlatt & Gordon, 1985)
Revised cognitive-behavioral model of relapse (Witkiewitz & Marlatt, 2004)
β Prev
61β78 of 78
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| AgboolaSMcNeillAColemanTLeonardi BeeJA systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokersAddiction20101051362138010.1111/j.1360-0443.2010.02996.x20653619 | β | β | β |
| AntonRFOrosziGO'MalleySCouperDSwiftRPettinatiHGoldmanDAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyArch Gen Psychiatry20086513514410.1001/archpsyc.65.2.13518250251PMC2666924 | β | β | β |
| ArmeliSTennenHAffleckGKranzlerHRDoes affect mediate the association between daily events and alcohol use?J Stud Alcohol2000618628711118849210.15288/jsa.2000.61.862 | β | β | β |
| BakerTBJapuntichSJHogleJMMcCarthyDECurtinJJPharmacologic and Behavioral Withdrawal from Addictive DrugsCurr Dir Psychol Sci20061523223610.1111/j.1467-8721.2006.00442.x | β | β | β |
| BakerTBPiperMEMcCarthyDEMajeskieMRFioreMCAddiction Motivation Reformulated: An Affective Processing Model of Negative ReinforcementPsychol Rev200411133511475658410.1037/0033-295X.111.1.33 | β | β | β |
| BanduraASelf-efficacy: The exercise of control1997New York: Freeman | β | β | β |
| BauerLOCovaultJHarelODasSGelernterJAntonRKranzlerHRVariation in GABRA2 predicts drinking behavior in project MATCH subjectsAlcohol Clin Exp Res2007311780178710.1111/j.1530-0277.2007.00517.x17949392PMC3169387 | β | β | β |
| BoutonMEA learning theory perspective on lapse, relapse, and the maintenance of behavior changeHealth Psychol20001957631070994810.1037/0278-6133.19.suppl1.57 | β | β | β |
| BowenSChawlaNCollinsSEWitkiewitzKHsuSGrowJClifasefiSGarnerMDouglassALarimerMEMarlattAMindfulness-based relapse prevention for substance use disorders: a pilot efficacy trialSubst Abus20093029530510.1080/0889707090325008419904665PMC3280682 | β | β | β |
| BowenSWitkiewitzKDillworthTMChawlaNSimpsonTLOstafinBDLarimerMEBlumeAWParksGAMarlattGAMindfulness meditation and substance use in an incarcerated populationPsychol Addict Behav2006203433471693807410.1037/0893-164X.20.3.343 | β | β | β |
| BrandonTHCollinsBNJulianoLMLazevABPreventing relapse among former smokers: A comparison of minimal interventions through telephone and mailJ Consult Clin Psychol2000681031131071084510.1037//0022-006x.68.1.103 | β | β | β |
| BrandonTHMeadeCDHerzogTAChirikosTNWebbMSCantorABEfficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: Dismantling the effects of amount of content versus contactJ Consult Clin Psychol2004727978081548203810.1037/0022-006X.72.5.797 | β | β | β |
| BrandonTHVidrineJILitvinEBRelapse and relapse preventionAnnu Rev Clin Psychol2007325728410.1146/annurev.clinpsy.3.022806.09145517716056 | β | β | β |
| BrownellKDMarlattGALichtensteinEWilsonGTUnderstanding and preventing relapseAm Psychol198641765782352700310.1037//0003-066x.41.7.765 | β | β | β |
| BrownRALejuezCWKahlerCWStrongDRDistress tolerance and duration of past smoking cessation attemptsJ Abnorm Psychol200211118018511866171 | β | β | β |
| CarrollKMRelapse prevention as a psychosocial treatment: A review of controlled clinical trialsExp Clin Psychopharmacol199644654 | β | β | β |
| CohenLMMcCarthyDMBrownSAMyersMGNegative affect combines with smoking outcome expectancies to predict smoking behavior over timePsychol Addict Behav20021691971207926010.1037//0893-164x.16.2.91 | β | β | β |
| ColillaSLermanCShieldsPGJepsonCRukstalisMBerlinJDeMicheleABuninGStromBLRebbeckTRAssociation of catechol-O-methyltransferase with smoking cessation in two independent studies of womenPharmacogenet Genomics20051539339810.1097/01213011-200506000-0000415900212PMC1262648 | β | β | β |
| COMBINE Study Research GroupTesting combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methodsAlcohol Clin Exp Res200327110711221287891710.1097/00000374-200307000-00011 | β | β | β |
| ContiDVLeeWLiDLiuJVan Den BergDThomasPDBergenAWSwanGETyndaleRFBenowitzNLLermanCNicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessationHum Mol Genet2008172834284810.1093/hmg/ddn18118593715PMC2525499 | β | β | β |
| CummingsCGordonJRMarlattGARelapse: Strategies of prevention and predictionThe addictive behaviors: Treatment of alcoholism, drug abuse, smoking, and obesity1980Oxford: Pergamon291321 | β | β | β |
| DimeffLAMarlattGAPreventing relapse and maintaining change in addictive behaviorsClin Psychol Sci Prac1998551352510.1111/j.1468-2850.1998.tb00171.x | β | β | β |
| DonovanDMCommentary on replications of Marlatt's taxonomy: Marlatt's classification of relapse precipitants: Is the emperor still wearing clothes?Addiction199691S131S13710.1111/j.1360-0443.1996.tb02333.x8997787 | β | β | β |
| DonovanDMMarlattGAAssessment of addictive behaviors20052New York: Guilford | β | β | β |
| DurazzoTCGazdzinskiSMonAMeyerhoffDJCortical perfusion in alcohol-dependent individuals during short-term abstinence: Relationships to resumption of hazardous drinking after treatmentAlcohol20104420121010.1016/j.alcohol.2010.03.00320682188PMC3038637 | β | β | β |
| FieldMWiersRWChristiansenPFillmoreMTVersterJCAcute alcohol effects on inhibitory control and implicit cognition: implications for loss of control over drinkingAlcohol Clin Exp Res201034134613522049173210.1111/j.1530-0277.2010.01218.xPMC2999764 | β | β | β |
| FilbeyFMRayLSmolenAClausEDAudetteAHutchisonKEDifferential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypesAlcohol Clin Exp Res2008321113112310.1111/j.1530-0277.2008.00692.x18540916PMC2856650 | β | β | β |
| GoldmanMSDarkesJDel BocaFKKirsch, IrvingExpectancy mediation of biopsychosocial risk for alcohol use and alcoholism1999Washington, DC, US: American Psychological Association.; 1999233262How expectancies shape experience | β | β | β |
| GwaltneyCJMetrikJKahlerCWShiffmanSSelf-efficacy and smoking cessation: a meta-analysisPsychol Addict Behav20092356661929069010.1037/a0013529PMC3829471 | β | β | β |
| GwaltneyCJShiffmanSBalabanisMHPatyJADynamic Self-Efficacy and Outcome Expectancies: Prediction of Smoking Lapse and RelapseJ Abnorm Psychol20051146616751635138710.1037/0021-843X.114.4.661 | β | β | β |
| GwaltneyCJShiffmanSNormalGJPatyJAKasselJDGnysMHickcoxMWatersABalabanisMDoes smoking abstinence self-efficacy vary across situations? Identifying context-specificity within the Relapse Situation Efficacy QuestionnaireJ Consult Clin Psychol20016951652711495181 | β | β | β |
| GwaltneyCJShiffmanSSayetteMASituational Correlates of Abstinence Self-EfficacyJ Abnorm Psychol20051146496601635138610.1037/0021-843X.114.4.649 | β | β | β |
| HajekPSteadLFWestRJarvisMLancasterTRelapse prevention interventions for smoking cessationCochrane Database Syst Rev2009CD00399910.1002/14651858.CD003999.pub319160228 | β | β | β |
| HendershotCSLindgrenKPLiangTHutchisonKECOMT and ALDH2 polymorphisms moderate associations of implicit drinking motives with alcohol useAddict Biol2011 in press 10.1111/j.1369-1600.2010.00286.xPMC311796421309949 | β | β | β |
| HendershotCSMarlattGAGeorgeWHShumaker S, Ockene JK, Riekert KRelapse prevention and the maintenance of optimal healthThe Handbook of Health Behavior Change20073New York: Springer Publishing Co | β | β | β |
| HendershotCSNeighborsCGeorgeWHMcCarthyDMWallTLLiangTLarimerMEALDH2, ADH1B and alcohol expectancies: integrating genetic and learning perspectivesPsychol Addict Behav2009234524631976942910.1037/a0016629PMC2761721 | β | β | β |
| HendershotCSOttoJMCollinsSELiangTWallTLEvaluation of a brief web-based genetic feedback intervention for reducing alcohol-related health risks associated with ALDH2Ann Behav Med201040778810.1007/s12160-010-9207-320652463PMC2977977 | β | β | β |
| HendershotCSWitkiewitzKGeorgeWHWallTLOttoJMLiangTLarimerMEEvaluating a cognitive model of ALDH2 and drinking behaviorAlcohol Clin Exp Res201135919810.1111/j.1530-0277.2010.01325.x21039630PMC3057511 | β | β | β |
| HerdNBorlandRHylandAPredictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country SurveyAddiction20091042088209910.1111/j.1360-0443.2009.02732.x19922574PMC4517970 | β | β | β |
| HerdNBorlandRThe natural history of quitting smoking: findings from the International Tobacco Control (ITC) Four Country SurveyAddiction20091042075208710.1111/j.1360-0443.2009.02731.x19922573PMC4535933 | β | β | β |
| HoMKGoldmanDHeinzAKaprioJKreekMJLiMDMunafoMRTyndaleRFBreaking barriers in the genomics and pharmacogenetics of drug addictionClin Pharmacol Ther20108877979110.1038/clpt.2010.17520981002PMC3738009 | β | β | β |
| HuffordMRWitkiewitzKShieldsALKodyaSCarusoJCRelapse as a nonlinear dynamic system: Application to patients with alcohol use disordersJ Abnorm Psychol20031122192271278483110.1037/0021-843x.112.2.219 | β | β | β |
| HumphreysKMcLellanATA policy-oriented review of strategies for improving the outcomes of services for substance use disorder patients*Addiction201110.1111/j.1360-0443.2011.03464.x21631620 | β | β | β |
| Hunter-ReelDMcCradyBHildebrandtTEmphasizing interpersonal factors: an extension of the Witkiewitz and Marlatt relapse modelAddiction20091041281129010.1111/j.1360-0443.2009.02611.x19549057PMC2714871 | β | β | β |
| HuntWABarnettLWBranchLGRelapse rates in addiction programsJ Clin Psychol19712745545610.1002/1097-4679(197110)27:4<455::AID-JCLP2270270412>3.0.CO;2-R5115648 | β | β | β |
| HussongAMHicksRELevySACurranPJSpecifying the relations between affect and heavy alcohol use among young adultsJ Abnorm Psychol20011104494611150208810.1037//0021-843x.110.3.449 | β | β | β |
| HutchisonKERayLSandmanERutterMCPetersADavidsonDSwiftRThe effect of olanzapine on craving and alcohol consumptionNeuropsychopharmacology200631131013171623739410.1038/sj.npp.1300917 | β | β | β |
| HutchisonKEWoodenASwiftRMSmolenAMcGearyJAdlerLParisLOlanzapine reduces craving for alcohol: A DRD4 VNTR polymorphism by pharmacotherapy interactionNeuropsychopharmacology2003281882188810.1038/sj.npp.130026412888781 | β | β | β |
| IrvinJEBowersCADunnMEWangMCEfficacy of relapse prevention: A meta-analytic reviewJ Consult Clin Psychol1999675635701045062710.1037//0022-006x.67.4.563 | β | β | β |
| JohnstoneECElliotKMDavidSPMurphyMFWaltonRTMunafoMRAssociation of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trialCancer Epidemiol Biomarkers Prev2007161065106910.1158/1055-9965.EPI-06-093617548664PMC2031911 | β | β | β |
| KatzECFrommeKD'AmicoEJEffects of outcome expectancies and personality on young adults' illicit drug use, heavy drinking, and risky sexual behaviorCognit Ther Res20002412210.1023/A:1005460107337 | β | β | β |
| KazdinAENockMKDelineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendationsJ Child Psychol Psychiatry2003441116112910.1111/1469-7610.0019514626454 | β | β | β |
| KirshenbaumAPOlsenDMBickelWKA quantitative review of the ubiquitous relapse curveJ Subst Abuse Treat20093681710.1016/j.jsat.2008.04.00118571890PMC3151675 | β | β | β |
| KramerDAGoldmanMSUsing a modified Stroop task to implicitly discern the cognitive organization of alcohol expectanciesJ Abnorm Psychol200311217117512653426 | β | β | β |
| LancasterTHajekPSteadLFWestRJarvisMJPrevention of relapse after quitting smoking: a systematic review of trialsArch Intern Med200616682883510.1001/archinte.166.8.82816636207 | β | β | β |
| LarimerMEPalmerRSMarlattGARelapse prevention: An overview of Marlatt's cognitive-behavioral modelAlcohol Res Health19992315116010890810PMC6760427 | β | β | β |
| LauMASegalZVWitkiewitz K, Marlatt GAMindfulness-based cognitive therapy as a relapse prevention approach to depressionTherapist's Guide to Evidence-Based Relapse Prevention2007London: Academic Press21771279 | β | β | β |
| LermanCShieldsPGWileytoEPAudrainJHawkLHJrPintoAKucharskiSKrishnanSNiauraREpsteinLHEffects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trialHealth Psychol2003225415481457053810.1037/0278-6133.22.5.541 | β | β | β |
| LermanCWileytoEPPattersonFRukstalisMAudrain-McGovernJRestineSShieldsPGKaufmannVReddenDBenowitzNBerrettiniWHThe functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trialPharmacogenomics J2004418419210.1038/sj.tpj.650023815007373 | β | β | β |
| LittMDKaddenRMStephensRSCoping and Self-Efficacy in Marijuana Treatment: Results From the Marijuana Treatment ProjectJ Consult Clin Psychol200573101510251639297510.1037/0022-006X.73.6.1015 | β | β | β |
| LongabaughRDonovanDMKarnoMPMcCradyBSMorgensternJToniganJSActive ingredients: How and why evidence-based alcohol behavioral treatment interventions workAlcohol Clin Exp Res20052923524710.1097/01.ALC.0000153541.78005.1F15714046 | β | β | β |
| MagillMRayLACognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trialsJ Stud Alcohol Drugs2009705165271951529110.15288/jsad.2009.70.516PMC2696292 | β | β | β |
| MaistoSAConnorsGJRelapse in the addictive behaviors: Integration and future directionsClin Psychol Rev20062622923110.1016/j.cpr.2005.11.00916360255 | β | β | β |
| MaistoSAConnorsGJZywiakWHReplication and extension of Marlatt's taxonomy: Construct validation analyses on the Marlatt typology of relapse precipitantsAddiction199691S89S9710.1111/j.1360-0443.1996.tb02329.x8997783 | β | β | β |
| MannKKieferFSmolkaMGannHWellekSHeinzASearching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT studyAlcohol Clin Exp Res20093367468310.1111/j.1530-0277.2008.00884.x19170666 | β | β | β |
| MarissenMAFrankenIHWatersAJBlankenPvan den BrinkWHendriksVMAttentional bias predicts heroin relapse following treatmentAddiction20061011306131210.1111/j.1360-0443.2006.01498.x16911730 | β | β | β |
| MarlattGABuddhist philosophy and the treatment of addictive behaviorCogn Behav Pract20029444910.1016/S1077-7229(02)80039-6 | β | β | β |
| MarlattGADonovanDMRelapse prevention: Maintenance strategies in the treatment of addictive behaviors20052New York: Guilford | β | β | β |
| MarlattGAGordonJRDavidson PO, Davidson SMDeterminants of relapse: Implications for the maintenance of behavior changeBehavioral Medicine: Changing health lifestyles1980New York: Brunner/Mazel410452 | β | β | β |
| MarlattGAGordonJRRelapse prevention: Maintenance strategies in the treatment of addictive behaviors1985New York: Guilford Press | β | β | β |
| MarlattGANathan PE, Marlatt GA, Loberg TCraving for alcohol, loss of control, and relapse: A cognitive-behavioral analysisAlcoholism: New directions in behavioral research and treatment1978New York: Plenum271314 | β | β | β |
| MarlattGAWitkiewitzKMarlatt G Alan, Donovan Dennis MRelapse Prevention for Alcohol and Drug Problems20052Relapse prevention: Maintenance strategies in the treatment of addictive behaviors1442005. | β | β | β |
| MarteauTMMunafoMRAveyardPHillCWhitwellSWillisTACrockettRAHollandsGJJohnstoneECWrightAJTrial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherenceBMC Public Health20101068010.1186/1471-2458-10-68021062464PMC2996370 | β | β | β |
| McCarthyDMThompsenDMImplicit and Explicit Measures of Alcohol and Smoking CognitionsPsychol Addict Behav2006204364441717617810.1037/0893-164X.20.4.436 | β | β | β |
| McCarthyDMWallTLBrownSACarrLGIntegrating biological and behavioral factors in alcohol use risk: The role of ALDH2 status and alcohol expectancies in a sample of Asian AmericansExp Clin Psychopharmacol200081681751084329910.1037//1064-1297.8.2.168 | β | β | β |
| McCradyBSAlcohol use disorders and the Division 12 Task Force of the American Psychological AssociationPsychol Addict Behav20001426727610998952 | β | β | β |
| McGovernMPWrisleyBRDrakeRERelapse of substance use disorder and its prevention among persons with co-occurring disordersPsychiatr Serv2005561270127310.1176/appi.ps.56.10.127016215194 | β | β | β |
| McKayJRCariseDDennisMLDupontRHumphreysKKempJReynoldsDWhiteWArmstrongRChalkMExtending the benefits of addiction treatment: practical strategies for continuing care and recoveryJ Subst Abuse Treat20093612713010.1016/j.jsat.2008.10.00519161893PMC2744393 | β | β | β |
| McKayJRFranklinTRPatapisNLynchKGConceptual, methodological, and analytical issues in the study of relapseClin Psychol Rev20062610912710.1016/j.cpr.2005.11.00216371242 | β | β | β |
| McLellanATHave we evaluated addiction treatment correctly? Implications from a chronic care perspectiveAddiction20029724925210.1046/j.1360-0443.2002.00127.x11964098 | β | β | β |
| MillerWRSection I. theoretical perspectives on relapse: What is a relapse? Fifty ways to leave the wagonAddiction199691S15S2710.1111/j.1360-0443.1996.tb02324.x8997778 | β | β | β |
| MillerWRWesterbergVSHarrisRJToniganJSWhat predicts relapse? Prospective testing of antecedent modelsAddiction199691SupplS1551728997790 | β | β | β |
| MillerWRWilbournePLMesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disordersAddiction20029726527710.1046/j.1360-0443.2002.00019.x11964100 | β | β | β |
| MirandaRRayLJustusAMeyersonLAKnopikVSMcGearyJMontiPMInitial evidence of an association between OPRM1 and adolescent alcohol misuseAlcohol Clin Exp Res20103411212210.1111/j.1530-0277.2009.01073.x19860800PMC3691683 | β | β | β |
| MorgensternJLongabaughRCognitive-behavioral treatment for alcohol dependence: A review of evidence for its hypothesized mechanisms of actionAddiction2000951475149010.1046/j.1360-0443.2000.951014753.x11070524 | β | β | β |
| MunafoMRJohnstoneECGuoBMurphyMFAveyardPAssociation of COMT Val108/158Met genotype with smoking cessationPharmacogenet Genomics20081812112810.1097/FPC.0b013e3282f44daa18192898 | β | β | β |
| MuravenMBaumeisterRFSelf-regulation and depletion of limited resources: Does self-control resemble a muscle?Psychol Bull20001262472591074864210.1037/0033-2909.126.2.247 | β | β | β |
| MuravenMCollinsRLMorsheimerETShiffmanSPatyJAThe Morning After: Limit Violations and the Self-Regulation of Alcohol ConsumptionPsychol Addict Behav2005192532621618780310.1037/0893-164X.19.3.253 | β | β | β |
| MuravenMCollinsRLShiffmanSPatyJADaily Fluctuations in Self-Control Demands and Alcohol IntakePsychol Addict Behav2005191401471601138410.1037/0893-164X.19.2.140 | β | β | β |
| MuravenMPracticing self-control lowers the risk of smoking lapsePsychol Addict Behav2010244464522085393010.1037/a0018545PMC2946169 | β | β | β |
| NiauraRCognitive social learning and related perspectives on drug cravingAddiction200095Suppl 2S1551631100291010.1080/09652140050111726 | β | β | β |
| O'ConnellKAHoseinVLSchwartzJELeibowitzRQHow Does Coping Help People Resist Lapses During Smoking Cessation?Health Psychol20072677841720970010.1037/0278-6133.26.1.77 | β | β | β |
| Office of National Drug Control PolicyNational Drug Control Strategy for 2010http://www.ondcp.gov10.1111/j.1749-6632.2009.05278.x20201863 | β | β | β |
| OotemanWNaassilaMKoeterMWVerheulRSchippersGMHouchiHDaoustMvan den BrinkWPredicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicatorsAddict Biol20091432833710.1111/j.1369-1600.2009.00159.x19523047 | β | β | β |
| OrleansCTPromoting the maintenance of health behavior change: Recommendations for the next generation of research and practiceHealth Psychol20001976831070995110.1037/0278-6133.19.suppl1.76 | β | β | β |
| OslinDWBerrettiniWKranzlerHRPettinatiHGelernterJVolpicelliJRO'BrienCPA Functional Polymorphism of the mu-Opioid receptor gene is associated with naltrexone response in alcohol-dependent patientsNeuropsychopharmacology2003281546155210.1038/sj.npp.130021912813472 | β | β | β |
| PaulusMPTapertSFSchuckitMANeural Activation Patterns of Methamphetamine-Dependent Subjects During Decision Making Predict RelapseArch Gen Psychiatry20056276176810.1001/archpsyc.62.7.76115997017 | β | β | β |
| PerkinsKALermanCMercincavageMFonteCABriskiJLNicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patchCancer Epidemiol Biomarkers Prev2009182608261210.1158/1055-9965.EPI-09-016619755656PMC2759850 | β | β | β |
| PiaseckiTMFioreMCBakerTBProfiles in discouragement: Two studies of variability in the time course of smoking withdrawal symptomsJ Abnorm Psychol19981072382512000960455310.1037//0021-843x.107.2.238 | β | β | β |
| PiaseckiTMJorenbyDESmithSSFioreMCBakerTBSmoking Withdrawal Dynamics: III. Correlates of Withdrawal HeterogeneityExp Clin Psychopharmacol2003112762851459926110.1037/1064-1297.11.4.276 | β | β | β |
| PiaseckiTMNiauraRShadelWGAbramsDGoldsteinMFioreMCBakerTBSmoking withdrawal dynamics in unaided quittersJ Abnorm Psychol200010974861074093810.1037//0021-843x.109.1.74 | β | β | β |
| PiaseckiTMRelapse to smokingClin Psychol Rev20062619621510.1016/j.cpr.2005.11.00716352382 | β | β | β |
| PolivyJHermanCPIf at first you don't succeed: False hopes of self-changeAm Psychol20025767768912237978 | β | β | β |
| Project MATCH Research GroupMatching alcoholism treatments to client heterogeneity: Project MATCH Posttreatment drinking outcomesJ Stud Alcohol1997587298979210 | β | β | β |
| RamchandaniVAUmhauJPavonFJRuiz-VelascoVMargasWSunHDamadzicREskayRSchoorMThorsellAA genetic determinant of the striatal dopamine response to alcohol in menMol Psychiatry2010 in press 10.1038/mp.2010.56PMC292505220479755 | β | β | β |
| RawsonRAShoptawSJObertJLMcCannMJHassonALMarinelli-CaseyPJBrethenPRLingWAn intensive outpatient approach for cocaine abuse treatment. The Matrix modelJ Subst Abuse Treat19951211712710.1016/0740-5472(94)00080-B7623389 | β | β | β |
| RayLAHutchisonKEA polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humansAlcohol Clin Exp Res2004281789179510.1097/01.ALC.0000148114.34000.B915608594 | β | β | β |
| RayRJepsonCWileytoEPDahlJPPattersonFRukstalisMPintoABerrettiniWLermanCGenetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trialNicotine Tob Res200791237124110.1080/1462220070164836717978999 | β | β | β |
| RothmanAJToward a theory-based analysis of behavioral maintenanceHealth Psychol20001964691070994910.1037/0278-6133.19.suppl1.64 | β | β | β |
| SchoenmakersTMde BruinMLuxIFGoertzAGVan KerkhofDHWiersRWClinical effectiveness of attentional bias modification training in abstinent alcoholic patientsDrug Alcohol Depend2010109303610.1016/j.drugalcdep.2009.11.02220064698 | β | β | β |
| ShadelWGCervoneDEvaluating social-cognitive mechanisms that regulate self-efficacy in response to provocative smoking cues: An experimental investigationPsychol Addict Behav20062091961653667110.1037/0893-164X.20.1.91 | β | β | β |
| ShiffmanSBalabanisMHPatyJAEngbergJGwaltneyCJLiuKSGnysMHickcoxMPatonSMDynamic effects of self-efficacy on smoking lapse and relapseHealth Psychol2000193153231090764910.1037//0278-6133.19.4.315 | β | β | β |
| ShiffmanSHickcoxMPatyJAGnysMKasselJDRichardsTJProgression from a smoking lapse to relapse: Prediction from abstinence violation effects, nicotine dependence, and lapse characteristicsJ Consult Clin Psychol1996649931002891662810.1037//0022-006x.64.5.993 | β | β | β |
| ShiffmanSWatersAJNegative Affect and Smoking Lapses: A Prospective AnalysisJ Consult Clin Psychol2004721922011506595410.1037/0022-006X.72.2.192 | β | β | β |
| StacyAWWiersRWImplicit cognition and addiction: a tool for explaining paradoxical behaviorAnnu Rev Clin Psychol2010655157510.1146/annurev.clinpsy.121208.13144420192786PMC3423976 | β | β | β |
| StantonMRelapse Prevention Needs More Emphasis on Interpersonal FactorsAm Psychol2005603403411594353210.1037/0003-066X.60.4.340 | β | β | β |
| StoneAAShiffmanSEcological momentary assessment (EMA) in behavorial medicineAnn Behav Med199416199202 | β | β | β |
| StoutRLLongabaughRRubinAReplication and extension of Marlatt's taxonomy: Predictive validity of Marlatt's relapse taxonomy versus a more general relapse codeAddiction199691S99S11010.1111/j.1360-0443.1996.tb02330.x8997784 | β | β | β |
| SturgessJEGeorgeTPKennedyJLHeinzAMullerDJPharmacogenetics of alcohol, nicotine and drug addiction treatmentsAddict Biol201110.1111/j.1369-1600.2010.00287.x21362114 | β | β | β |
| UhlGRLiuQRDrgonTJohnsonCWaltherDRoseJEDavidSPNiauraRLermanCMolecular genetics of successful smoking cessation: convergent genome-wide association study resultsArch Gen Psychiatry20086568369310.1001/archpsyc.65.6.68318519826PMC2430596 | β | β | β |
| van den WildenbergEWiersRWDessersJJanssenRGJHLambrichsEHSmeetsHJMvan BreukelenGJPA functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkersAlcohol Clin Exp Res20073111010.1111/j.1530-0277.2006.00258.x17207095 | β | β | β |
| VolkowNDFowlerJSWangGJThe addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategiesNeuropharmacology200447Suppl 13131546412110.1016/j.neuropharm.2004.07.019 | β | β | β |
| WallsTASchaferJLModels for Intensive Longitudinal Data2006New York: Oxford University Press | β | β | β |
| WatersAJShiffmanSSayetteMAPatyJAGwaltneyCJBalabanisMHAttentional bias predicts outcome in smoking cessationHealth Psychol2003223783871294039410.1037/0278-6133.22.4.378PMC2244587 | β | β | β |
| WiersRWBartholowBDvan den WildenbergEThushCEngelsRCSherKJGrenardJAmesSLStacyAWAutomatic and controlled processes and the development of addictive behaviors in adolescents: A review and a modelPharmacol Biochem Behav20078626328310.1016/j.pbb.2006.09.02117116324 | β | β | β |
| WiersRWRinckMDictusMvan den WildenbergERelatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-alleleGenes Brain Behav2009810110610.1111/j.1601-183X.2008.00454.x19016889 | β | β | β |
| WiersRWStacyAWHandbook of implicit cognition and addiction2006Handbook of implicit cognition and addiction. Thousand Oaks, CA: Sage Publications2006. | β | β | β |
| WitkiewitzKBowenSDepression, craving, and substance use following a randomized trial of mindfulness-based relapse preventionJ Consult Clin Psychol2010783623742051521110.1037/a0019172PMC3280693 | β | β | β |
| WitkiewitzKBowenSDonovanDMModerating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependenceJ Consult Clin Psychol20117954632126143410.1037/a0022282PMC3157314 | β | β | β |
| WitkiewitzKHartzlerBDonovanDMatching motivation enhancement treatment to client motivation: re-examining the Project MATCH motivation matching hypothesisAddiction20101051403141310.1111/j.1360-0443.2010.02954.x20491723PMC3157315 | β | β | β |
| WitkiewitzKMarlattGAModeling the complexity of post-treatment drinking: it's a rocky road to relapseClin Psychol Rev20072772473810.1016/j.cpr.2007.01.00217355897PMC1995671 | β | β | β |
| WitkiewitzKMarlattGARelapse prevention for alcohol and drug problems: That was Zen, this is TaoAm Psychol2004592242351514926310.1037/0003-066X.59.4.224 | β | β | β |
| WitkiewitzKMarlattGATherapist's Guide to Evidence-Based Relapse Prevention2007London: Academic Press21771279 | β | β | β |
| WitkiewitzKMarlattGAWalkerDMindfulness-Based Relapse Prevention for Alcohol and Substance Use DisordersJ Cogn Psychother20051921122810.1891/jcop.2005.19.3.211 | β | β | β |
| WitkiewitzKvan der MaasHLJHuffordMRMarlattGANonnormality and divergence in posttreatment alcohol use: Reexamining the Project MATCH data "another way."J Abnorm Psychol20071163783941751676910.1037/0021-843X.116.2.378PMC2048690 | β | β | β |
| WitkiewitzKVillarroelNADynamic association between negative affect and alcohol lapses following alcohol treatmentJ Consult Clin Psychol2009776336441963495710.1037/a0015647PMC2911993 | β | β | β |
| WitkiewitzKVillarroelNAHartzlerBDonovanDMDrinking outcomes following drink refusal skills training: Differential effects for African American and non-Hispanic White clientsPsychol Addict Behav2011251621672144331110.1037/a0022254PMC4159945 | β | β | β |
| WojnarMBrowerKJStrobbeSIlgenMMatsumotoHNowosadISliwerskaEBurmeisterMAssociation between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependenceAlcohol Clin Exp Res20093369370210.1111/j.1530-0277.2008.00886.x19170664PMC2928673 | β | β | β |
| YoungRMLawfordBRFeeneyGFXRitchieTNobleEPAlcohol-related expectancies are associated with the D2 dopamine receptor and GABA receptor beta3 subunit genesPsychiatry Res200412717118310.1016/j.psychres.2003.11.00415296817 | β | β | β |
| ZgierskaARabagoDChawlaNKushnerKKoehlerRMarlattAMindfulness meditation for substance use disorders: a systematic reviewSubst Abus20093026629410.1080/0889707090325001919904664PMC2800788 | β | β | β |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genetic influences on craving for alcohol. | 2013 | 22481050 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Effects of a Sequential Community-Based Multi Component HIV Intervention on Sexual Behavior, Drug Use and Syringe Sharing for People Who Inject Drugs on the US-Mexico Border: A Quasi-Experimental Study. | Lechuga J et al. | β | 2026 | β |
| A remotely delivered exercise-based rehabilitation program for patients with persistent chemotherapy-induced peripheral neuropathy (EX-CIPN): Protocol for a phase I feasibility trial. | Antonen EM et al. | β | 2025 | β |
| Cognitive Dysfunction in the Addictions (CDiA): protocol for a neuron-to-neighbourhood collaborative research program. | Nikolova YS et al. | β | 2025 | β |
| Epigenetic Dysregulation in Alcohol-Associated Behaviors: Preclinical and Clinical Evidence. | Domi E et al. | β | 2025 | β |
| Exploration of Effective Substance Use Relapse Prevention Programmes for the Youth: An Integrative Literature Review. | Gaolaolwe W et al. | β | 2025 | β |
| Integrated Detoxification in Inpatient Substance Use Disorder Treatment: A Way to Prevent Dropouts and Overdoses. | Bergly TH et al. | β | 2025 | β |
| Maximizing Engagement, Trust, and Clinical Benefit of AI-Generated Recovery Support Messages for Alcohol Use Disorder: Protocol for an Optimization Study. | Wyant K et al. | β | 2025 | β |
| Mindfulness-based interventions for binge eating: an updated systematic review and meta-analysis. | Liu J et al. | β | 2025 | β |
| Psychological triggers and behavioral mechanisms of relapse in social media addiction. | Cao X et al. | β | 2025 | β |
| Responding to location-based triggers of cravings to return to substance use: A qualitative study. | Viera A et al. | β | 2025 | β |
| The Development of a Patient-Centered Digital Health Care Technology for Young Adults in Opioid Use Disorder Treatment: Qualitative Study. | Alexander K et al. | β | 2025 | β |
| The Resilience on Amphetamine Relapse Youth Scale: development and psychometric properties. | Uthis P et al. | β | 2025 | β |
| Virtual Reality in Prevention and Treatment of Substance-Related Disorders: A Systematic Review of Randomized Controlled Trials. | Glavak-TkaliΔ R et al. | β | 2025 | β |
| A Qualitative Exploration of Attitudes Toward Global Positioning System Tracking and Ecological Momentary Assessment Among Individuals in Substance Use Treatment. | Viera A et al. | β | 2024 | β |
| Determinants and prevalence of relapse among patients with substance use disorder in a rural population: A retrospective observational study. | Suwanchatchai C et al. | β | 2024 | β |
| Determinants of Smoking Cessation Outcomes and Reasons for Relapse in Patients Admitted to a Smoking Cessation Outpatient Clinic in Turkey. | Acar T et al. | β | 2024 | β |
| Development and Feasibility Pilot Study of Indigenous Recovery Planning: A Community-Engaged Approach to Addressing Substance Use in a Native Community. | Skewes MC et al. | β | 2024 | β |
| Internet Addiction Management: A Comprehensive Review of Clinical Interventions and Modalities. | Chadha Y et al. | β | 2024 | β |
| Latent profiles of regulatory flexibility in alcohol use disorder: Associations with delay discounting and symptoms of depression, anxiety, and stress. | Dwyer CL et al. | β | 2024 | β |
| Role of Acamprosate and Baclofen as Anti-craving Agents in Alcohol Use Disorder: A 12-Week Prospective Study. | Sharma AK et al. | β | 2024 | β |
| Sociodemographic and treatment-related determinants of recent substance use among adults with comorbid substance misuse and psychotic disorders discharged from substance use treatment. | Moore J et al. | β | 2024 | β |
| The Food Addiction Clinical Treatment (FACT) Manual: A Harm Reduction Treatment Approach. | O'Hea EL et al. | β | 2024 | β |
| Using Latent Profile Analysis to Examine Cannabis Use Contexts: Associations with Use, Consequences, and Protective Behaviors. | Gray BA et al. | β | 2024 | β |
| 'You Can Die With Me But I Won't Let You Live With Me', Exploring Social Influences on the Continuation of Heroin Use in Men Who Use Heroin. | Houghton B et al. | β | 2024 | β |
| Alcohol use disorder in community management of chronic liver diseases. | Leggio L et al. | β | 2023 | β |
| Automaticity: schema modes in addiction. | Boog M et al. | β | 2023 | β |
| Early maladaptive schemas in substance use disorders in the Indian context: Theoretical and therapeutic implications. | Chopra R et al. | β | 2023 | β |
| Effects of an online program including mindfulness, exercise therapy and patient education compared to online exercise therapy and patient education for people with Patellofemoral Pain: protocol for a randomized clinical trial. | Priore LBD et al. | β | 2023 | β |
| Implementation of a relapse prevention program among smokers undergoing arthroplasty: lessons learned. | Wilker OG et al. | β | 2023 | β |
| Integrated cognitive behavioral treatment for substance use and depressive symptoms: a homeless case series and feasibility study. | Molander O et al. | β | 2023 | β |
| Predictors of polysubstance use in patients with severe alcohol use disorder: the role of reward craving. | Di Nicola M et al. | β | 2023 | β |
| Predictors of smoking cessation outcomes identified by machine learning: A systematic review. | Bickel WK et al. | β | 2023 | β |
| Treatment effects and adherence of sexually compulsive men in a randomized controlled trial of psychotherapy and medication. | Scanavino MDT et al. | β | 2023 | β |
| Using ecological momentary assessments of negative affect and craving during residential opioid use disorder treatment to predict patients' relapse to substance use. | Cleveland HH et al. | β | 2023 | β |
| A matter of craving-An archeology of relapse prevention in Swedish addiction treatment. | Ekendahl M et al. | β | 2022 | β |
| A pilot randomized trial of CBT4CBT for women in residential treatment for substance use disorders. | Kelpin SS et al. | β | 2022 | β |
| A Randomized Clinical Trial to Assess the Efficacy of a Psychological Treatment to Quit Smoking Assisted with an App: Study Protocol. | LΓ³pez-DurΓ‘n A et al. | β | 2022 | β |
| A review of functional brain differences predicting relapse in substance use disorder: Actionable targets for new methods of noninvasive brain stimulation. | Gibson BC et al. | β | 2022 | β |
| A specific cognitive behavioral group therapy program for stimulant use disorder. | Karsinti E et al. | β | 2022 | β |
| Comparative effectiveness of mindfulness and mindful eating programmes among low-income overweight women in primary health care: A randomised controlled pragmatic study with psychological, biochemical, and anthropometric outcomes. | Salvo V et al. | β | 2022 | β |
| Daily support seeking as coping strategy in dual-smoker couples attempting to quit. | Schwaninger P et al. | β | 2022 | β |
| Effectiveness of Mindfulness - Based Therapy and Counseling programs (MBTC) on relapses to methamphetamine dependence at a substance dependency treatment center. | Maneesang W et al. | β | 2022 | β |
| Effectiveness of Remote Intensive Counseling Versus Outpatient Counseling in Substance Use Disorders: A Retrospective Cohort Study. | Ntchana A et al. | β | 2022 | β |
| Feasibility and preliminary effectiveness of internet-mediated 'relapse prevention therapy' for patients with alcohol use disorder: A pilot study. | Sharma A et al. | β | 2022 | β |
| Former inpatients' narratives of substance use four years after substance use disorder treatment: A qualitative follow-up study. | Hystad J et al. | β | 2022 | β |
| Galanin N-terminal fragment (1-15) reduces alcohol seeking and alcohol relapse in rats: Involvement of mesocorticolimbic system. | Cantero-GarcΓa N et al. | β | 2022 | β |
| Hazardous drinking and alcohol use disorders. | MacKillop J et al. | β | 2022 | β |
| Heightened cocaine-seeking in male rats associates with a distinct transcriptomic profile in the medial prefrontal cortex. | Merritt CR et al. | β | 2022 | β |
| Infralow neurofeedback in the treatment of substance use disorders: a randomized controlled trial. | Gabrielsen KB et al. | β | 2022 | β |
| Lapse and Relapse Rates in Narcotics Anonymous versus Methadone Maintenance Treatment: A 12-Month Prospective Study. | Mohseni F et al. | β | 2022 | β |
| Lifetime use of non-nicotine drugs in electronic cigarette devices among a sample of individuals in substance use disorder treatment. | Masson CL et al. | β | 2022 | β |
| Long-term relapse prevention strategies among poly-substance users in Ghana: New insights for clinical practice. | Appiah R | β | 2022 | β |
| Personal Social Networks and Relapses in Women With Substance Dependence: Application of the Theory of Planned Behavior. | Kim H et al. | β | 2022 | β |
| Predictors of Relapse to Alcohol and Substance Use: Are There Any Differences between 3 and 12 Months after Inpatient Treatment? | Guliyev C et al. | β | 2022 | β |
| The indirect effect of negative emotionality via alcohol craving on abstinence self-efficacy among women in alcohol treatment. | Altman BR et al. | β | 2022 | β |
| Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study. | Feliu A et al. | β | 2022 | β |
| TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society. | NΓ©stor S et al. | β | 2022 | β |
| User engagement with technology-mediated self-guided interventions for addictions: scoping review protocol. | Brazeau BW et al. | β | 2022 | β |
| Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients. | Forget B et al. | β | 2021 | β |
| A Theory- and Evidence-Based Digital Intervention Tool for Weight Loss Maintenance (NoHoW Toolkit): Systematic Development and Refinement Study. | Marques MM et al. | β | 2021 | β |
| Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review. | Houghton B et al. | β | 2021 | β |
| Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male. | Sonia JA et al. | β | 2021 | β |
| Daily associations among craving, affect, and social interactions in the lives of patients during residential opioid use disorder treatment. | Knapp KS et al. | β | 2021 | β |
| Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre. | Kabisa E et al. | β | 2021 | β |
| Effectiveness of a Dyadic Buddy App for Smoking Cessation: Randomized Controlled Trial. | Schwaninger P et al. | β | 2021 | β |
| Efficacy and acceptability of interventions for co-occurring PTSD and SUD: A meta-analysis. | Simpson TL et al. | β | 2021 | β |
| Electronic cigarettes' withdrawal severity symptoms among users during intermittent fasting: a cross-sectional study. | Barakat MM et al. | β | 2021 | β |
| Emerging Adults in Inpatient Substance Use Treatment: A Prospective Cohort Study of Patient Characteristics and Treatment Outcomes. | Andersson HW et al. | β | 2021 | β |
| Neurobiology of alcohol seeking behavior. | Domi E et al. | β | 2021 | β |
| Prospective Prediction of Lapses in Opioid Use Disorder: Protocol for a Personal Sensing Study. | Moshontz H et al. | β | 2021 | β |
| Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial. | Schmitz JM et al. | β | 2021 | β |
| The Clinical Course of Alcohol Use Disorder Depicted by Digital Biomarkers. | ZetterstrΓΆm A et al. | β | 2021 | β |
| The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. | Torous J et al. | β | 2021 | β |
| The use and impact of self-monitoring on substance use outcomes: A descriptive systematic review. | Gass JC et al. | β | 2021 | β |
| Where there's a will, there's a way? Strategies to reduce or abstain from alcohol use developed by Northern Plains American Indian women participating in a brief, alcohol-exposed pregnancy preconceptual intervention. | Deutsch AR et al. | β | 2021 | β |
| Alcohol use disorder and liver transplant: new perspectives and critical issues. | Gitto S et al. | β | 2020 | β |
| A Reinforcer Pathology perspective on relapse. | Bickel WK et al. | β | 2020 | β |
| Biomarkers and neuromodulation techniques in substance use disorders. | Habelt B et al. | β | 2020 | β |
| Can a Smartphone App for Cannabis Cessation Gain a Broader User Group than Traditional Treatment Services? | Vederhus JK et al. | β | 2020 | β |
| Daily Automated Telephone Assessment and Intervention Improved 1-Month Outcome in Paroled Offenders. | Andersson C et al. | β | 2020 | β |
| Effectiveness of the e-Tabac Info Service application for smoking cessation: a pragmatic randomised controlled trial. | Affret A et al. | β | 2020 | β |
| Experimental manipulations of behavioral economic demand for addictive commodities: a meta-analysis. | Acuff SF et al. | β | 2020 | β |
| Exploring substance use disorders and relapse in Mauritian male addicts. | Ramsewak S et al. | β | 2020 | β |
| Incidence and Risk Factors of Alcohol Relapse after Liver Transplantation: Analysis of Pre-Transplant Abstinence and Psychosocial Features. | Yu TW et al. | β | 2020 | β |
| Long-term treatment retention in West Virginia's comprehensive opioid addiction treatment (COAT) program. | Lander LR et al. | β | 2020 | β |
| Neuromodulation of brain activation associated with addiction: A review of real-time fMRI neurofeedback studies. | Martz ME et al. | β | 2020 | β |
| Perspectives Emerged from Students and Supervisory Staff Interaction in Drug Use Prevention: A Q Methodology Investigation. | Huang CM et al. | β | 2020 | β |
| PPARΞ³ activation by pioglitazone does not suppress cravings for alcohol, and is associated with a risk of myopathy in treatment seeking alcohol dependent patients: a randomized controlled proof of principle study. | Schwandt ML et al. | β | 2020 | β |
| Reducing Risky Alcohol Use <i>via</i> Smartphone App Skills Training Among Adult Internet Help-Seekers: A Randomized Pilot Trial. | Berman AH et al. | β | 2020 | β |
| The protective role of emotional intelligence in smoking relapse during a 12-month follow-up smoking cessation intervention. | MegΓas-Robles A et al. | β | 2020 | β |
| Abstinence Following a Motivation-Skill-Desensitization-Mental Energy Intervention for Heroin Dependence: A Three-year Follow-up Result of a Randomized Controlled Trial. | Chen JY et al. | β | 2019 | β |
| Alcohol use disorder relapse factors: A systematic review. | Sliedrecht W et al. | β | 2019 | β |
| A review of behavioral alcohol interventions for transplant candidates and recipients with alcohol-related liver disease. | Schlagintweit HE et al. | β | 2019 | β |
| Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation. | Sokol R et al. | β | 2019 | β |
| Commentary on Cohn and Colleagues: Discussions of Alcohol Use in an Online Social Network for Smoking Cessation: Analysis of Topics, Sentiment, and Social Network Centrality (ACER, 2019). | Ashford RD et al. | β | 2019 | β |
| Current understanding of the neurobiology of opioid use disorder: An overview. | Moningka H et al. | β | 2019 | β |
| Disruption of relapse to alcohol seeking by aversive counterconditioning following memory retrieval | Goltseker K et al. | β | 2019 | β |
| Implementations of a text-message intervention to increase linkage from the emergency department to outpatient treatment for substance use disorders. | Kmiec J et al. | β | 2019 | β |
| Individual Vulnerability to Stress Is Associated With Increased Demand for Intravenous Heroin Self-administration in Rats. | Stafford NP et al. | β | 2019 | β |
| Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial. | Zgierska AE et al. | β | 2019 | β |
| Models and theories of health behavior and clinical interventions in aging: a contemporary, integrative approach. | Rejeski WJ et al. | β | 2019 | β |
| Partnering with Native Communities to Develop a Culturally Grounded Intervention for Substance Use Disorder. | Skewes MC et al. | β | 2019 | β |
| Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances. | Andersson HW et al. | β | 2019 | β |
| Relationship between Type D personality and dropout from dental treatment in middle-aged adults. | Kato T et al. | β | 2019 | β |
| Students' experiences of a facial morphing intervention designed to encourage safer drinking. | Owen AL et al. | β | 2019 | β |
| The association of maternal alcohol use and paraprofessional home visiting with children's health: A randomized controlled trial. | Rotheram-Borus MJ et al. | β | 2019 | β |
| The NoHoW protocol: a multicentre 2Γ2 factorial randomised controlled trial investigating an evidence-based digital toolkit for weight loss maintenance in European adults. | Scott SE et al. | β | 2019 | β |
| Trajectories of change after a health-education program in Japan: decay of impact in anxiety, depression, and patient-physician communication. | Park MJ et al. | β | 2019 | β |
| A mindful model of sexual health: A review and implications of the model for the treatment of individuals with compulsive sexual behavior disorder. | Blycker GR et al. | β | 2018 | β |
| A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder. | Dimet AL et al. | β | 2018 | β |
| Assessing heart rate variability biofeedback as an adjunct to college recovery housing programs. | Eddie D et al. | β | 2018 | β |
| Borderline personality disorder: an adaptation of the Taiwan short version of the screening inventory into Brazilian Portuguese. | Coronato-Nunes T et al. | β | 2018 | β |
| Cognitive behavioural interventions in addictive disorders. | Sudhir PM | β | 2018 | β |
| Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder. | Maisto SA et al. | β | 2018 | β |
| Development and psychometric properties of the methamphetamine decisional balance scale (METH-DBS) for young adults. | Khazaee-Pool M et al. | β | 2018 | β |
| Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers. | Lim AC et al. | β | 2018 | β |
| Effectiveness of Mindfulness-based Relapse Prevention on Quality of Life and Craving in Methadone-treated Patients: A Randomized Clinical Trial. | Yaghubi M et al. | β | 2018 | β |
| Feasibility and Effects of Digital Interventions to Support People in Recovery From Substance Use Disorders: Systematic Review. | NesvΓ₯g S et al. | β | 2018 | β |
| Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence. | Witkiewitz K et al. | β | 2018 | β |
| Psychological interventions for behavioral adjustments in diabetes care - a value-based approach to disease control. | Chew BH et al. | β | 2018 | β |
| Relapse prevention. | Menon J et al. | β | 2018 | β |
| The new social work. | Patterson Silver Wolf DA | β | 2018 | β |
| To identify predictors of relapse in cases of alcohol dependence syndrome in relation to life events. | Chauhan VS et al. | β | 2018 | β |
| Acceptability of an Opioid Relapse Prevention Text-message Intervention for Emergency Department Patients. | Suffoletto B et al. | β | 2017 | β |
| An mHealth App for Supporting Quitters to Manage Cigarette Cravings With Short Bouts of Physical Activity: A Randomized Pilot Feasibility and Acceptability Study. | Hassandra M et al. | β | 2017 | β |
| A Smarter Pathway for Delivering Cue Exposure Therapy? The Design and Development of a Smartphone App Targeting Alcohol Use Disorder. | Mellentin AI et al. | β | 2017 | β |
| Daily Assessment of Acute Dynamic Risk in Paroled Offenders: Prediction, Predictive Accuracy and Intervention Effect. | Vasiljevic Z et al. | β | 2017 | β |
| Developing a Fitbit-supported lifestyle physical activity intervention for depressed alcohol dependent women. | Abrantes AM et al. | β | 2017 | β |
| Evaluation of a community-based integrated heroin addiction treatment model in Chinese patients. | Zhang HH et al. | β | 2017 | β |
| Evaluation of an integrated group cognitive-behavioral treatment for comorbid mood, anxiety, and substance use disorders: A pilot study. | Milosevic I et al. | β | 2017 | β |
| Interactive Voice Response with Feedback Intervention in Outpatient Treatment of Substance Use Problems in Adolescents and Young Adults: A Randomized Controlled Trial. | Andersson C et al. | β | 2017 | β |
| The Impact of Self-Criticism and Self-Reassurance on Weight-Related Affect and Well-Being in Participants of a Commercial Weight Management Programme. | Duarte C et al. | β | 2017 | β |
| Alcohol Consumption, Craving, and Craving Control Efforts Assessed Daily in the Context of Readiness to Change Among Individuals with Alcohol Dependence and PTSD. | Browne KC et al. | β | 2016 | β |
| Do Alcohol Relapse Episodes During Treatment Predict Long-Term Outcomes? Investigating the Validity of Existing Definitions of Alcohol Use Disorder Relapse. | Maisto SA et al. | β | 2016 | β |
| Exercise as an adjunctive treatment for cannabis use disorder. | Brellenthin AG et al. | β | 2016 | β |
| Is the Construct of Relapse Heuristic, and Does It Advance Alcohol Use Disorder Clinical Practice? | Maisto SA et al. | β | 2016 | β |
| Stressful Events and Other Predictors of Remission from Drug Dependence in the United States: Longitudinal Results from a National Survey. | McCabe SE et al. | β | 2016 | β |
| The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial. | Gustafson DH et al. | β | 2016 | β |
| Theoretical, Critical, and Practical Reflections on the Long-Term Maintenance of Health Behavior Change. | Giacobbi PR | β | 2016 | β |
| Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories. | Kwasnicka D et al. | β | 2016 | β |
| Alexithymia, emotional dysregulation, and recovery from alcoholism: therapeutic response to assessment of mood. | Krentzman AR et al. | β | 2015 | β |
| A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine. | Stein MD et al. | β | 2015 | β |
| Effectiveness of a Mobile Phone App for Adults That Uses Physical Activity as a Tool to Manage Cigarette Craving After Smoking Cessation: A Study Protocol for a Randomized Controlled Trial. | Hassandra M et al. | β | 2015 | β |
| mHealth App for Cannabis Users: Satisfaction and Perceived Usefulness. | Monney G et al. | β | 2015 | β |
| Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial. | Witkiewitz K et al. | β | 2015 | β |
| Predictors of posttreatment drinking outcomes in patients with alcohol dependence. | FlΓ³rez G et al. | β | 2015 | β |
| Randomized controlled trial of a minimal versus extended Internet-based intervention for problem drinkers: study protocol. | Cunningham JA et al. | β | 2015 | β |
| Recidivism Among Licensed-Released Prisoners Who Participated in the EM Program in Israel. | Shoham E et al. | β | 2015 | β |
| Relapse Prevention and the Five Rules of Recovery. | Melemis SM | β | 2015 | β |
| Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. | Howell LL et al. | β | 2015 | β |
| Smokers Show Lower Levels of Psychological Well-Being and Mindfulness than Non-Smokers. | Barros VV et al. | β | 2015 | β |
| A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomes. | Brown RA et al. | β | 2014 | β |
| Effects of depressive symptoms on antecedents of lapses during a smoking cessation attempt: an ecological momentary assessment study. | Brodbeck J et al. | β | 2014 | β |
| Laboratory-induced cue reactivity among individuals with prescription opioid dependence. | Back SE et al. | β | 2014 | β |
| Motivations toward smoking cessation, reasons for relapse, and modes of quitting: results from a qualitative study among former and current smokers. | Buczkowski K et al. | β | 2014 | β |
| Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. | Cunningham KA et al. | β | 2014 | β |
| Variation within the serotonin (5-HT) 5-HTβC receptor system aligns with vulnerability to cocaine cue reactivity. | Anastasio NC et al. | β | 2014 | β |
| A narrative review of yoga and mindfulness as complementary therapies for addiction. | Khanna S et al. | β | 2013 | β |
| Are AMPA receptor positive allosteric modulators potential pharmacotherapeutics for addiction? | Watterson LR et al. | β | 2013 | β |
| Distinct coping strategies differentially predict urge levels and lapses in a smoking cessation attempt. | Brodbeck J et al. | β | 2013 | β |
| Genetic influences on craving for alcohol. | Agrawal A et al. | β | 2013 | β |
| Hidden decay of impact after education for self-management of chronic illnesses: hypotheses. | Park MJ et al. | β | 2013 | β |
| Neuroimaging mechanisms of change in psychotherapy for addictive behaviors: emerging translational approaches that bridge biology and behavior. | Feldstein Ewing SW et al. | β | 2013 | β |
| Problematic alcohol use in clients recovering from drug dependence--time to adjust our focus. | Ross J | β | 2013 | β |
| Relationship of reasons and fears of treatment with outcome in substance using population attending a de-addiction centre. | Sarkar S et al. | β | 2013 | β |
| Translational neuroscience and potential contributions of functional magnetic resonance imaging (FMRI) to the prevention of substance misuse and antisocial behavior. | Whitten LA | β | 2013 | β |
| Polymorphisms of the serotonin transporter and receptor genes: susceptibility to substance abuse. | Herman AI et al. | β | 2012 | β |